SAFETY AND EFFICACY OF EARLY USE OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS VS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: HEPHAISTOS STUDY 12 MONTHS DATA

被引：0
|
作者：
Schlitt, H. J. [1 ]
Nashan, B. [1 ]
Schemmer, P. [1 ]
Pascher, A. [1 ]
Klein, C. G. [1 ]
Neumann, U. [1 ]
Kroeger, I. [2 ]
Wimmer, P. [2 ]
Braun, F. [1 ]
机构：
[1] Hephaistos Study Grp, Nurnberg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
V079
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [21] EARLY EVEROLIMUS PLUS REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS RESULTS IN SUPERIOR RENAL FUNCTION AND SUSTAINS OVER 24 MONTHS: RESULTS OF A RANDOMIZED TRIAL
    De Simone, P.
    Fischer, L.
    Kaiser, G.
    Jonas, S.
    Heise, M.
    Schemmer, P.
    Pascher, A.
    Schlitt, H.
    Paulus, E.
    Mertens, M.
    Duvoux, C.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 3 - 3
  • [22] COST EFFECTIVENESS OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS
    Park, T.
    Griggs, S.
    Horwedel, T.
    Hagopian, J.
    Bowman, L.
    VALUE IN HEALTH, 2016, 19 (03) : A315 - A315
  • [23] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
  • [24] EVALUATING THE EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS VERSUS STANDARD TACROLIMUS IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS: H2307 STUDY DESIGN
    Sips, C.
    Suh, K. S.
    Joh, J. W.
    Yoshizumi, T.
    Lee, W. C.
    Genyk, Y.
    Martzloff, E. -D.
    Wang, Z.
    Lopez, P.
    Grant, D.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S858 - S859
  • [25] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
    Saliba, F.
    Duvoux, C.
    Durand, F.
    Neau-Cransac, M.
    Hardwigsen, J.
    Pageaux, G.
    Di Giambattista, F.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18
  • [26] EFFICACY AND SAFETY OF EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID ELIMINATION REGIMEN IN DE NOVO PEDIATRIC RENAL TRANSPLANT RECIPIENTS: 12-MONTH DATA FROM THE CRADLE STUDY.
    Toenshoff, B.
    Ettenger, R.
    Christian, M.
    Bjerre, A.
    Strologo, L. D.
    Marks, S. D.
    Pape, L.
    Martzloff, E-D.
    Rauer, B.
    Ng, J.
    Lopez, P. M.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 1 - 1
  • [27] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Jiang, Hai
    Junge, Guido
    HEPATOLOGY, 2011, 54 : 1430A - 1431A
  • [28] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 24 MONTHS
    Duvoux, C.
    Saliba, F.
    Durand, F.
    Neau-Cransac, N.
    Hardwigsen, J.
    Pageaux, G.
    Boleslawski, E.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 2 - 2
  • [29] Design of a Randomized Study Aimed To Evaluate the Efficacy and Safety of Everolimus with Reduced Exposure Tacrolimus Versus Standard Tacrolimus in Living Donor Liver Transplant Recipients.
    Song, G. W.
    Chen, C. L.
    Lee, W. C.
    Joh, J. W.
    Levy, G.
    Pomfret, E.
    Lopez, P. M.
    Guido, J.
    Hexham, J. M.
    Uemoto, S.
    Suh, K. S.
    LIVER TRANSPLANTATION, 2013, 19 : S155 - S155
  • [30] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
12345